ERDOTIN Capsules, hard Ref.[8577] Active ingredients: Erdosteine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Galen Limited, Seagoe Industrial Estate, Craigavon, BT63 5UA, UK

Therapeutic indications

As an expectorant.

For the symptomatic treatment of acute exacerbations of chronic bronchitis in adults.

Posology and method of administration

Elderly and adults above 18 years: 300 mg twice daily for maximum 10 days.

The capsules must be swallowed whole with a glass of water.

Overdose

No experience of acute overdosage is available.

Symptomatic treatment and general supportive measures should be followed in all cases of overdosage.

Gastric lavage may be beneficial, followed by observation.

Shelf life

Shelf life: 3 years.

Special precautions for storage

Do not store above 25°C.

Nature and contents of container

Each PVC/PVdC/Aluminium blister pack contains 10 capsules. Pack-sizes of 20 or 60 capsules per carton.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.